1300 66 55 41

Dr Stephanie Lim

Medical Oncologist

Dr Stephanie Lim is a staff specialist medical oncologist at Macarthur Cancer Centre and conjoint lecturer at Western Sydney University and University of New South Wales. She is a clinical research fellow at the Ingham Institute for Applied Medical Research where she completed a translational PhD in 2017. She received the South Western Sydney Local Health District and Ingham Institute Research Grant in 2015, and was awarded the Dean’s List Award from the University of New South Wales in 2015. She received the Ingham colorectal grant in 2018.
Dr Lim has published more than 20 peer-reviewed papers and presented more than 30 abstracts in the past 6 years. She is a co-supervisor of 3 PhD students. She was chief investigator in a multicentre prospective longitudinal study in the South West Sydney Local Health District (SWSLHD), investigating circulating tumour cells in locally advanced rectal cancer. She also collaborates with the department of anatomical pathology on a colorectal cancer tissue microarray-based database at SWSLHD. She is involved in colorectal cancer clinical trials at Macarthur Cancer Centre. She has served as reviewer for multiple peer-reviewed journals including Annals of Oncology, and is on the editorial board for Cancer Letters. She has also served as external reviewer for NHMRC.


C1 - Journal Article

E1 - Conference Abstract

  • Lim S, Ng W, Chua W, Descallar J, Spring K, De Souza P 2015, Quality of life and circulating tumour cells in patients treated with neoadjuvant chemoradiation for rectal cancer - is there a link?, European Cancer Congress, ELSEVIER SCI LTD, vol. 51, p. S224
  • Lim SH, Ng W, Chua W, Descallar J, Spring K, De Souza P 2015, Psychological parameters and circulating tumor cells in locally advanced rectal cancer, WILEY-BLACKWELL, vol. 11, p. 57
  • Lim S, Chua W, Ng W, Descallar J, Bokey L, Spring K, De Souza P 2015, Presence of circulating tumour cells and correlation with inflammatory markers in non-metastatic rectal cancer, European Cancer Congress, ELSEVIER SCI LTD, vol. 51, p. S391